Cornerstone Advisors (Washington)’s DexCom DXCM Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$202K	Buy	1,964 +24	+1%	+$2.51K	0.02%	106
2020 Q2	$197K	Buy	1,940 +956	+97%	+$85.5K	0.02%	101
2020 Q1	$66K	Buy	984 +212	+27%	+$13.2K	0.01%	184
2019 Q4	$42K	Buy	772 +64	+9%	+$3.04K	0.01%	257
2019 Q3	$26K	Buy	708 +212	+43%	+$8.24K	﹤0.01%	306
2019 Q2	$19K	Buy	496 +360	+265%	+$11.3K	﹤0.01%	637
2019 Q1	$4K	Buy	+136	New	+$4.78K	﹤0.01%	858
2017 Q4	–	Sell	-1,480	Closed	-$18K	–	916
2017 Q3	$18K	Sell	1,480 -616	-29%	-$10.9K	0.01%	498
2017 Q2	$38K	Hold	2,096	–	–	0.02%	328
2017 Q1	$44K	Hold	2,096	–	–	0.02%	290
2016 Q4	$31K	Hold	2,096	–	–	0.03%	361
2016 Q3	$46K	Hold	2,096	–	–	0.04%	266
2016 Q2	$42K	Buy	2,096 +388	+23%	+$6.61K	0.04%	173
2016 Q1	$29K	Hold	1,708	–	–	0.03%	229
2015 Q4	$35K	Sell	1,708 -32	-2%	-$666	0.04%	232
2015 Q3	$37K	Buy	+1,740	New	+$38.8K	0.03%	216

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Cornerstone Advisors (Washington)'s DXCM Position: Q3 2020 in Review

Cornerstone Advisors (Washington) increased its DexCom (DXCM) stake by 1.2% in Q3 2020, buying an estimated $2.51K and bringing the position to 1,964 shares worth $202K. The position accounts for 0.02% of the portfolio, ranked #106.

Cornerstone Advisors (Washington) first reported a position in DXCM in Q3 2015 and has held it in 16 quarters since. 728 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

Cornerstone Advisors (Washington) held 1,964 shares of DexCom worth $202K as of Q3 2020.
Cornerstone Advisors (Washington) bought 24 DexCom shares in Q3 2020, an estimated $2.51K.
DexCom made up 0.02% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #106 holding.
Cornerstone Advisors (Washington) first reported a position in DexCom in Q3 2015 and has held it in 16 quarters since.
728 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.